AstraZeneca to Sell Caprelsa to Sanofi's Genzyme for Up to $300M By: Benzinga via Benzinga July 27, 2015 at 05:29 AM EDT AstraZeneca (NYSE: AZN) today announced that it has entered into a definitive agreement with Genzyme (NYSE: SNY) to divest Caprelsa® ... Read More >> Related Stocks: Astrazeneca Plc ADR Macy's Sanofi-Aventis S.A. ADR